Skip to content

Effects of Parenteral and Enteral Nutrition on Skeletal Muscle Genomics

Effects of Parenteral and Enteral Nutrition on Skeletal Muscle Genomics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05080816
Enrollment
39
Registered
2021-10-18
Start date
2017-02-01
Completion date
2018-10-18
Last updated
2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Loss

Keywords

Skeletal muscle

Brief summary

The study investigates effects related to muscle protein metabolism at provision of Parenteral or enteral nutrition

Detailed description

Randomized study investigation alterations in muscle protein metabolism at provision of parenteral or enteral (oral drink) nutrition. The study uses a genomic/transcriptomic/proteomic approach to evaluate factors related to activation of skeletal muscle protein synthesis and protein degradation. Patients scheduled for major gastrointestinal surgery are included. Muscle specimens are collected during surgery.

Interventions

DIETARY_SUPPLEMENTEnteral nutrition

Oral nutrition drink. 2 \* 200 ml on the night before operation. 1\* 200 ml on the morning of operation day.

OTHERControl

Overnight infusion of crystalloid fluid (Ringer acetate) infused at the same rate (ml/kg) as intervention PN

DIETARY_SUPPLEMENTParenteral nutrition (PN)

Overnight infusion of parenteral nutrition. Supplied as all-in-one-bag format. Infusion rate of 0.2 g N/kg/day.

Sponsors

Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Masking description

Persons responsible for genomic/transcriptomic/proteomics analyses are blinded. All samples are coded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Major gastrointestinal surgery. * Assumed need of post-operative nutrition support.

Exclusion criteria

* Insulin dependent diabetes. * Steroid medication.

Design outcomes

Primary

MeasureTime frameDescription
Muscle protein metabolism~12-14 hours.Alterations in skeletal muscle gene expression quantified by microarray

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026